APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples